» Articles » PMID: 20161889

Self-reported Use of Traditional, Complementary and Over-the-counter Medicines by HIV-infected Patients on Antiretroviral Therapy in Pretoria, South Africa

Overview
Date 2010 Feb 18
PMID 20161889
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Current management of HIV involves the use of conventional prescription medicines, called 'antiretroviral drugs' (ARV), over-the-counter (OTC), complementary and alternative medicines (CAM), as well as African traditional medicine (ATM). The aim of this study was to determine the prevalence of use of traditional, complementary and over-the-counter medicines. A cross-sectional survey of HIV-infected patients who started ART between July 2004 and August 2005 at Dr George Mukhari Hospital (Pretoria), who consented to be interviewed, was conducted. Using a pre-tested structured questionnaire, data were collected by two trained interviewers on sociodemographic characteristics, and on non-prescribed medicines used of three sources: African traditional medicine (ATM), complementary and alternative medicine (CAM), and over-the-counter (OTC) medicines. The 180 patients who consented to be interviewed had a mean age of 36.7 (+/-8.1) years old; 68.8% were female, 86.7% unemployed, 73.9% with high school level of education, 77.8% single. Some 8.9% of respondents used at least one non-prescribed medicine. In descending order, 4.4% of respondents used ATM, 3.3% CAM, and 1.7% OTC medicines. The ATM products used included unspecified traditional mixtures, and those made of the African potato (Hypoxis hemerocallidea), and coconut (Cocos nucifera); OTC products used were paracetamol and sennosides (Senokot) tablets as well as a soap containing triclosan 1.5%; CAM products used were "sex booster" capsules of unknown composition, mercury-containing soaps (Mekako), and the Zion Church of Christ special tea, a mixture of Rooibos tea (Aspalathus linearis) plus sunflower oil (Helianthus annuus) and prayed for. In conclusion, only 8.9% of HIV-infected patients on ART in this study used a limited range of over-the-counter products as well as those from traditional, complementary and alternative medicine practices.

Citing Articles

An study to elucidate the effects of product Nkabinde on immune response in peripheral blood mononuclear cells of healthy donors.

Setlhare B, Letsoalo M, Nkabinde S, Nkabinde M, Mzobe G, Mtshali A Front Pharmacol. 2024; 15:1308913.

PMID: 38533263 PMC: 10963514. DOI: 10.3389/fphar.2024.1308913.


Propagation of Medicinal Plants for Sustainable Livelihoods, Economic Development, and Biodiversity Conservation in South Africa.

Fajinmi O, Olarewaju O, van Staden J Plants (Basel). 2023; 12(5).

PMID: 36904034 PMC: 10007054. DOI: 10.3390/plants12051174.


Potential challenges to sustained viral load suppression in the HIV treatment programme in South Africa: a narrative overview.

Bessong P, Matume N, Tebit D AIDS Res Ther. 2021; 18(1):1.

PMID: 33407664 PMC: 7788882. DOI: 10.1186/s12981-020-00324-w.


Traditional, complementary and alternative medicine use in Sub-Saharan Africa: a systematic review.

James P, Wardle J, Steel A, Adams J BMJ Glob Health. 2018; 3(5):e000895.

PMID: 30483405 PMC: 6231111. DOI: 10.1136/bmjgh-2018-000895.


Prevalence and factors associated with the use of traditional medicines among human immunodeficiency virus and acquired immunodeficiency syndrome patients in Sokoto, Nigeria.

Oche O, Sadiq U, Oladigbolu R, Chinna K Ann Afr Med. 2018; 17(3):125-132.

PMID: 30185681 PMC: 6126049. DOI: 10.4103/aam.aam_39_17.


References
1.
Miller L . Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med. 1998; 158(20):2200-11. DOI: 10.1001/archinte.158.20.2200. View

2.
Tsao J, Dobalian A, Myers C, Zeltzer L . Pain and use of complementary and alternative medicine in a national sample of persons living with HIV. J Pain Symptom Manage. 2005; 30(5):418-32. PMC: 1420635. DOI: 10.1016/j.jpainsymman.2005.05.012. View

3.
Wiwanitkit V . The use of CAM by HIV-positive patients in Thailand. Complement Ther Med. 2003; 11(1):39-41. DOI: 10.1016/s0965-2299(02)00108-5. View

4.
Fairfield K, EISENBERG D, Davis R, Libman H, Phillips R . Patterns of use, expenditures, and perceived efficacy of complementary and alternative therapies in HIV-infected patients. Arch Intern Med. 1998; 158(20):2257-64. DOI: 10.1001/archinte.158.20.2257. View

5.
Duggan J, Peterson W, Schutz M, Khuder S, Charkraborty J . Use of complementary and alternative therapies in HIV-infected patients. AIDS Patient Care STDS. 2001; 15(3):159-67. DOI: 10.1089/108729101750123661. View